skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines idarucizumabQuestion & answer

idarucizumab · Medicine question

Are any contraindications listed for idarucizumab?

iatroX medicinesPublished 8 November 2026

The answer

Answer

No contraindications are listed for idarucizumab.

Sources for this answer

Praxbind 2.5 g/50 mL solution for injection/infusionBoehringer Ingelheim Limited · emc · SmPC §4.3 Contraindications · Version 12Document updated 17 January 2025

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

idarucizumab

Read the wider context, including uses, precautions and the sources behind this medicine guide.

More questions about idarucizumab

Are data available on the effects of idarucizumab on fertility?Does transient proteinuria after idarucizumab administration indicate kidney damage?Have any adverse reactions been identified for idarucizumab?Have preclinical investigations shown interactions between idarucizumab and prothrombin complex concentrates?Have the safety and efficacy of Praxbind (idarucizumab) been established in children under 18 years?How does idarucizumab neutralise dabigatran’s anticoagulant effect?

Read the idarucizumab guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX